Differences

This shows you the differences between two versions of the page.

--- home:alternate:autoimmunity [03.27.2016] – [Evolutionary challenge] typo sallieq
+++ home:alternate:autoimmunity [10.13.2018] – [Rethinking autoimmunity] sallieq
@@ Line 22: / Line 22: @@
-[{{ :home:alternate:sarcoidosiscathelicidin.001.png?370|**If anything, patients with autoimmune disease are //immunocompromised//.** A study of the prevalence of the key antimicrobial peptide showed that patients with sarcoidosis expressed it less than healthy subjects, and that sicker sarcoidosis patients expressed it least of all. Source: [[http://meeting.chestpubs.org/cgi/content/abstract/136/4/127S-a|Kanchwala et al.]]}}]
+[{{ :home:alternate:sarcoidosiscathelicidin.001.png?370|**If anything, patients with autoimmune disease are //immunocompromised//.** A study of the prevalence of the key antimicrobial peptide showed that patients with sarcoidosis expressed it less than healthy subjects, and that sicker sarcoidosis patients expressed it least of all. Source: Kanchwala et al.}}]
 ===== Autoimmune patients show signs of being immunocompromised =====
@@ Line 129: / Line 129: @@
 There's no reason to think that other bacteria can do just as much damage – or that any pathogenic bacteria, for that matter, can interfere with production of autoantibodies.
+{{tag>Alternate_models}}
 ===== Notes and comments =====

home/alternate/autoimmunity.txt · Last modified: 09.14.2022 by 127.0.0.1